USPTO serial 76285153
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carla B. Oakley, Esq.
CARLA B OAKLEY ESQ BROBECK PHLEGER & HARRISON LLPSPEAR ST TWRONE MARKETSAN FRANCISCO, CA 94105| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Bio chemicals, namely, engineered proteins for the regulation of human, plant and microbial genes for use in scientific research, pharmaceutical research, agricultural biotechnology and industrial biotechnology | ACTIVE | Jul 1, 1995 |
| 005 | Bio chemicals, namely, engineered proteins for the regulation of human, plant and microbial genes for clinical and medical laboratory use in human therapeutics, DNA diagnostics and conformations | ACTIVE | Jul 1, 1995 |
| 042 | Medical and scientific research and technical consultation in the fields of conformations and gene regulation; research and development of engineered proteins for others; design of genetic research tools and systems for others | ACTIVE | Jul 1, 1995 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2002 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jan 24, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2001 | DOCK | ASSIGNED TO EXAMINER | — |